How drugmakers exploit the patent system to delay competition and inflate prices
Enabling competition between therapeutic alternatives is crucial to lowering costs for PBMs’ clients and patients.
Read MoreExpress Scripts by Evernorth Members Paid Less for Their Share of Prescriptions in 2023 Despite Drug Price Increases
Members with employer-sponsored insurance saw about a 1% decrease in their portion out-of-pocket costs for their prescription medicines last year, paying an average of $15.10 for a 30-day supply
Read MoreExpress Scripts modifies Medicare performance bonus pool process to continue focus on quality while improving cash flow to pharmacies
Read More
The power of drug optimization
As plan sponsors consider impactful ways to manage spend in 2024 and beyond, the power of drug optimization should not be overlooked.
Read MoreWhat impact will the Inflation Reduction Act have on health plans?
Plan sponsors should be aware of the effects the law will have on Medicare Part D over the coming years.
Read MoreExpress Scripts in 2023: Supporting clients, patients, and health plans
Over the last 12 months, Express Scripts has rolled out numerous groundbreaking programs and projects. Learn about some of the most notable advancements and innovations of 2023.
Read More